In tumours with microsatellite instability (MSI), which are highly mutated and generally respond well to ICB, mutations in HLA-B were enriched compared to non-MSI tumours [16], possibly rendering these tumours resistant to ICB. This evidence concerns the gene HLA-B and neoplasm.